• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Atopic Dermatitis 
Trial Solutions

Advanced clinical monitoring, streamlined data collection, and customized solutions to improve study outcomes and patient experience

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing Atopic Dermatitis research

Atopic dermatitis is the most common inflammatory disease condition in the world. Despite its prevalence, clinical assessments for atopic dermatitis are extremely complex. Between the various scoring scales used and the wide range of patients, it can be a challenge to achieve consistency across the study. That's where Signant Health's solutions can help.

Atopic Derm

Navigate Atopic Dermatitis Trial Challenges & Meet Goals

  • Accommodate Pediatric Patients
  • Eliminate Between-Scale Inconsistencies
  • Standardize Rater Training
  • Improve Endpoint Reliability
  • Assess Diverse Skin Types Properly
  • Digitalize Your Trial from End-to-End
  • Accommodate Pediatric Patients

    Accommodate Pediatric Patients

    Our flexible platform enables implementation of different patient-reported outcome instrument versions based on the individual’s age as well as offers the caregiver access needed for younger patients

  • Eliminate Between-Scale Inconsistencies

    Eliminate Between-Scale Inconsistencies
    Atopic dermatology trials often include multiple clinician-reported outcome scales, which can contain overlapping assessment areas such as body surface area (BSA) assessment. With approval of scale authors, Signant Health combined the three common scales (SCORAD, EASI, and BSA) into a single, custom assessment. Our novel implementation simplifies data collection by reducing the unnecessary need for duplicate assessments and decreasing inter-scale inconsistencies.

  • Standardize Rater Training

    Standardize Rater Training

    Our targeted atopic dermatology rater training standardizes clinician-reported outcome (ClinRO) scales, limits the augmentation of placebo responses, and improves assessment techniques. Designed and implemented by experienced clinician raters, Rater Training and Qualification prevents inter- and intra-rater variability from impacting your signal detection.

  • Improve Endpoint Reliability

    Improve Endpoint Reliability

    Our centralized statistical monitoring of blinded data identifies outliers, patterns, inconsistencies, trends, and potential fraud so you can make the necessary adjustments. Led by experienced data experts and clinicians, our blinded data analytics solution provides actionable insights to reduce noise and improve the power to successfully detect signals.

  • Assess Diverse Skin Types Properly

    Assess Diverse Skin Types Properly
    We've worked with leading dermatologists to create an exclusive set of training images that represent the diversity of skin types required in global clinical trials.

  • Digitalize Your Trial from End-to-End

    Digitalize Your Trial from End-to-End

    While all of our Signant SmartSignals solutions can be used as standalone tools, they seamlessly integrate with one another to further enhance the accuracy and efficiency of your atopic dermatitis study.

Comprehensive Atopic Dermatitis experience

0

TRIALS

0

COUNTRIES

0

PATIENTS

0

SITES

Explore Our Atopic Dermatitis Trial Resources
SOLUTION BROCHURE

Atopic Dermatitis Trial Solutions Overview

GET INSIGHTS
VIDEO

Atopic Dermatitis Trial Solutions

WATCH [2 MIN]
ARTICLE

Properly Training Physicians in Dermatology Trials (Applied Clinical Trials)

READ ARTICLE

Solutions Tailored for Atopic Dermatitis trials

Ready to learn more?

Discover how Signant can support your current or upcoming atopic dermatitis trials. 

DOWNLOAD BROCHURE GET STARTED